These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8851159)

  • 1. The antiaggressive potency of (-)-penbutolol involves both 5-HT1A and 5-HT1B receptors and beta-adrenoceptors.
    Sánchez C; Arnt J; Moltzen EK
    Eur J Pharmacol; 1996 Feb; 297(1-2):1-8. PubMed ID: 8851159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of relative efficacies of 5-HT1A receptor ligands by means of in vivo animal models.
    Sánchez C; Arnt J; Moltzen E
    Eur J Pharmacol; 1996 Nov; 315(3):245-54. PubMed ID: 8982661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
    Sánchez C; Hyttel J
    Eur J Pharmacol; 1994 Nov; 264(3):241-7. PubMed ID: 7698161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction studies of 5-HT1A receptor antagonists and selective 5-HT reuptake inhibitors in isolated aggressive mice.
    Sànchez C
    Eur J Pharmacol; 1997 Sep; 334(2-3):127-32. PubMed ID: 9369340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol.
    Hjorth S; Sharp T
    J Pharmacol Exp Ther; 1993 May; 265(2):707-12. PubMed ID: 8098761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male mice.
    Sánchez C; Arnt J; Hyttel J; Moltzen EK
    Psychopharmacology (Berl); 1993; 110(1-2):53-59. PubMed ID: 7870899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats.
    Sánchez C; Mørk A
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):287-94. PubMed ID: 10422888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of 5-HT1A receptor ligands by drug discrimination.
    Wolff MC; Leander JD
    Eur J Pharmacol; 1997 Aug; 333(2-3):113-22. PubMed ID: 9314023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
    Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
    Hillegaart V; Ahlenius S
    Br J Pharmacol; 1998 Dec; 125(8):1733-43. PubMed ID: 9886765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice.
    Alhaider AA; Wilcox GL
    J Pharmacol Exp Ther; 1993 Apr; 265(1):378-85. PubMed ID: 7682614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties.
    Assié MB; Koek W
    Eur J Pharmacol; 1996 May; 304(1-3):15-21. PubMed ID: 8813579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.